Recent studies have shown that amyloid-β (Aβ) directly activated astrocytic NF-κB and C3 release, consistent with the high expression of C3 seen in patients with Alzheimer’s disease [33]. Here, NFKB1 is linked to early-onset autosomal dominant Alzheimer disease.